Medication info

DuoWell A Plus Tablets 40/10/10/5 mg

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tabletRosuvastatin Calcium›10.4mg / 1 tabletEzetimibe›10mg / 1 tabletAmlodipine Besylate›6.944mg / 1 tablet
Manufacturer / importer
Yuhan Corporation
Appearance
Pink oval film-coated tablets
Packaging
30 tablets/box [6 tablets/PTP X 5]
Approval status
Active

MFDS item code 202202140 · Approved 2022.05.20

Summary

Main use
Treatment of hypertension and dyslipidemia (hypercholesterolemia and mixed dyslipidemia)
Who takes it
Adults
Adult dose
This medicine is for adults only. The dosage should be individualized for each patient based on the efficacy and tolerability of the telmisartan/amlodipine combination and the rosuvastatin/ezetimibe combination. The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Swallow this medicine whole; do not chew, divide, or crush it. ○ Telmisartan/amlodipine The recommended dose of the telmisartan/amlodipine combination is once daily. It is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan) before administering the telmisartan/amlodipine combination. However, if blood pressure is not controlled with the individual components as described below, switching directly to the telmisartan/amlodipine combination may be considered. - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or the telmisartan/amlodipine combination 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Older adults: In older adults aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be initiated at a low dose and the dose increased gradually. ○ Rosuvastatin/ezetimibe Patients must continue to follow a standard cholesterol-lowering diet before and during treatment with the rosuvastatin/ezetimibe combination. The dose of the rosuvastatin/ezetimibe combination should be adjusted according to the patient's baseline LDL cholesterol level, the recommended treatment target, and the patient's response. Primary hypercholesterolemia The dosage range of the rosuvastatin/ezetimibe combination is 5/10mg∼20/10mg once daily. The recommended initial dose is 5/10mg once daily. For patients requiring a greater reduction in LDL cholesterol, the dose may be adjusted. After starting treatment with the rosuvastatin/ezetimibe combination or adjusting the dose, check blood lipid levels after an interval of at least 4 weeks and adjust the dose accordingly; the dose may be increased up to a maximum of 20/10mg daily. For patients taking the telmisartan/amlodipine combination and the rosuvastatin/ezetimibe combination concomitantly, they may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.

Ingredients

Manufacturer
Yuhan Corporation

Efficacy & effects

Treatment of hypertension and dyslipidemia (hypercholesterolemia and mixed dyslipidemia)

  • Essential hypertension
  • primary hypercholesterolemia
  • mixed dyslipidemia
View approved original text

This medication is used for patients who require simultaneous administration of a combination of telmisartan and amlodipine, as well as rosuvastatin and ezetimibe. It helps in cases where sufficient blood pressure control is difficult with monotherapy using amlodipine or telmisartan for essential hypertension. Additionally, it lowers levels of bad cholesterol and triglycerides while raising good cholesterol in patients with primary hypercholesterolemia, familial and non-familial hypercholesterolemia, and mixed dyslipidemia. This medication is effective for the additional management of hypertension and dyslipidemia when used in conjunction with dietary adjustments. Thus, it is used to improve blood pressure and serum lipid levels.

How to take

Adult dose

This medicine is for adults only. The dosage should be individualized for each patient based on the efficacy and tolerability of the telmisartan/amlodipine combination and the rosuvastatin/ezetimibe combination. The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Swallow this medicine whole; do not chew, divide, or crush it. ○ Telmisartan/amlodipine The recommended dose of the telmisartan/amlodipine combination is once daily. It is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan) before administering the telmisartan/amlodipine combination. However, if blood pressure is not controlled with the individual components as described below, switching directly to the telmisartan/amlodipine combination may be considered. - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or the telmisartan/amlodipine combination 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Older adults: In older adults aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be initiated at a low dose and the dose increased gradually. ○ Rosuvastatin/ezetimibe Patients must continue to follow a standard cholesterol-lowering diet before and during treatment with the rosuvastatin/ezetimibe combination. The dose of the rosuvastatin/ezetimibe combination should be adjusted according to the patient's baseline LDL cholesterol level, the recommended treatment target, and the patient's response. Primary hypercholesterolemia The dosage range of the rosuvastatin/ezetimibe combination is 5/10mg∼20/10mg once daily. The recommended initial dose is 5/10mg once daily. For patients requiring a greater reduction in LDL cholesterol, the dose may be adjusted. After starting treatment with the rosuvastatin/ezetimibe combination or adjusting the dose, check blood lipid levels after an interval of at least 4 weeks and adjust the dose accordingly; the dose may be increased up to a maximum of 20/10mg daily. For patients taking the telmisartan/amlodipine combination and the rosuvastatin/ezetimibe combination concomitantly, they may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.

Precautions

This medication can pose a serious risk to the fetus during pregnancy, so if pregnancy is confirmed, administration should be stopped immediately. Muscle-related side effects may occur, so if symptoms such as myalgia or muscle weakness appear, consult a physician immediately. It may affect liver function; therefore, use this medication cautiously in patients with liver disease or suspected liver dysfunction. It should be administered carefully in patients with impaired renal function, and regular kidney function tests and serum electrolyte tests are important. As this medication lowers blood pressure, symptoms of hypotension may occur, and extra caution is necessary in cases of fluid or sodium deficiency. There may be interactions with other medications, so inform your physician or pharmacist about any other medications you are taking. It is advisable to avoid or limit alcohol consumption while using this medication, and be cautious of dizziness or drowsiness when driving or operating machinery. Do not use this medication if you have had allergies or hypersensitivity reactions to specific components. Elderly patients or patients with certain conditions require careful monitoring and dose adjustments. Regular blood tests and health assessments according to the physician's instructions are safe before and during administration.

Side effects

  • Eyelid damage
  • head injury
  • urinary difficulties
  • flushing
  • chronic gastritis
  • various gastrointestinal disorders
  • hiatal hernia
  • facial edema
  • abnormal sensations
  • drug intolerance
Show 197 more
  • chest pain
  • irritable bowel syndrome
  • colon polyps
  • esophagitis
  • dizziness
  • drowsiness
  • neurodegenerative disorders
  • positional dizziness
  • migraine
  • diabetes
  • impaired glucose tolerance
  • depression
  • bronchitis
  • rhinitis
  • cystitis
  • onychomycosis
  • soft tissue infection
  • hepatic steatosis
  • liver dysfunction
  • hepatotoxicity
  • acute hepatitis
  • toxic hepatitis
  • increased gamma-glutamyl transferase
  • increased blood cholesterol
  • increased blood alkaline phosphatase
  • irregular heartbeat
  • osteoarthritis
  • osteoporosis
  • musculoskeletal stiffness
  • musculoskeletal discomfort
  • muscle weakness
  • cold sweat
  • dermatitis
  • skin burning
  • skin disorders
  • alopecia
  • oropharyngeal pain
  • nasal congestion
  • respiratory distress
  • pelvic pain
  • breast cysts
  • eyelid drooping
  • diabetic retinopathy
  • ear discomfort
  • renal dysfunction
  • benign esophageal neoplasm
  • upper respiratory infection
  • urinary tract infection
  • sepsis
  • anemia
  • thrombocytopenia
  • eosinophilia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • depression
  • insomnia
  • anxiety
  • syncope
  • visual disturbances
  • dizziness
  • bradycardia
  • tachycardia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • abdominal pain
  • diarrhea
  • dyspepsia
  • abdominal bloating
  • vomiting
  • abdominal discomfort
  • dry mouth
  • abnormal liver function
  • hepatic impairment
  • increased sweating
  • itching
  • rash
  • erythema
  • angioedema
  • drug rash
  • toxic skin rash
  • eczema
  • hives
  • myalgia
  • back pain
  • muscle cramps
  • arthralgia
  • limb pain
  • tendon pain
  • acute renal failure
  • chest pain
  • weakness
  • influenza-like illness
  • increased serum creatinine
  • increased serum uric acid
  • elevated serum creatine kinase
  • decreased hemoglobin
  • angioedema
  • vasculitis
  • tension increased
  • sensory loss
  • sensory abnormalities
  • peripheral neuropathy
  • taste disturbances
  • tremor
  • extrapyramidal symptoms
  • erectile dysfunction
  • changes in bowel habits
  • gingival hypertrophy
  • pancreatitis
  • vomiting
  • hyperglycemia
  • leukopenia
  • thrombocytopenia
  • insomnia
  • mood changes
  • rhinitis
  • hair loss
  • hyperhidrosis
  • purpura
  • skin discoloration
  • hives
  • toxic epidermal necrolysis
  • tinnitus
  • visual disturbances
  • increased urinary frequency
  • urinary disorders
  • nocturia
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • headache
  • facial spasms
  • sensory abnormalities
  • paralysis
  • hyperventilation
  • pneumonia
  • flushing
  • erectile dysfunction
  • loss of appetite
  • edema
  • decreased libido
  • conjunctivitis
  • tinnitus
  • petechial hemorrhage
  • headache
  • dizziness
  • cough
  • hyperventilation
  • weakness
  • edema
  • facial swelling
  • rash
  • alopecia
  • conjunctival hyperemia
  • renal failure
  • abnormal liver function
  • fatigue
  • chest pain
  • chest discomfort
  • weakness
  • systemic edema
  • diabetic neuropathy
  • tremors
  • upper abdominal pain
  • vomiting
  • gastritis
  • constipation
  • dry mouth
  • epigastric discomfort
  • belching
  • gastrointestinal disorders
  • gastroesophageal reflux disease
  • tongue disorders
  • palpitations
  • congestive heart failure
  • myocardial ischemia
  • sputum
  • limb pain
  • arthralgia
  • diabetes
  • hypoglycemia
  • anemia
  • splenomegaly
  • hives
  • hyperhidrosis
  • rash
  • itching
  • upper respiratory infection
  • renal failure
  • increased serum creatinine
  • elevated blood pressure
  • increased blood urea
  • increased CPK
  • abnormal liver function tests

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. Additionally, it should be stored at room temperature between 1 to 30 degrees Celsius, away from extreme heat or cold.

Appearance and packaging

Appearance

Pink oval film-coated tablets

Package unit

30 tablets/box [6 tablets/PTP X 5]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.